tradingkey.logo
tradingkey.logo
Search

Agilent Technologies Inc

A
Add to Watchlist
139.740USD
0.0000.00%
Close 07-23 16:00ETQuotes delayed by 15 min
39.44BMarket Cap
30.71P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-07-23
Previous score
8.00
Change
0
The current earnings forecast score of Agilent Technologies Inc is 8.00, ranking 69 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 167.50, with a high of 185.00 and a low of 149.86.

Analyst Rating

Based on 24 analysts
Buy
Current Rating
159.560
Target Price
+20.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Agilent Technologies Inc
A
24
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

What is Agilent Technologies Inc's expected revenue for the next quarter?

Agilent Technologies Inc's expected revenue is 1.84B.

What is Agilent Technologies Inc's price target?

Analysts forecast that Agilent Technologies Inc's price target is USD 167.50, with the highest forecast at USD 185.00 and the lowest forecast at USD 149.86.

How have Agilent Technologies IncA's recent earnings per share performed?

The market expectation was USD 1.20, while Agilent Technologies IncA's earnings per share (EPS) for the previous quarter was USD 1.08. EPS for the next quarter is expected at USD 1.49.

What is the analyst rating for Agilent Technologies Inc?

Based on the ratings of Agilent Technologies Inc's stock from 24 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.